Transportation Healthcare Sector

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Pediatrix Medical Group

Market Cap: US$1.2b

Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

Ocular Therapeutix

Market Cap: US$1.1b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

ANI Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

U.S. Physical Therapy

Market Cap: US$1.1b

Operates and manages outpatient physical therapy clinics.

Kestra Medical Technologies

Market Cap: US$1.1b

Operates as a wearable medical device and digital healthcare company.

Amphastar Pharmaceuticals

Market Cap: US$1.1b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Pulse Biosciences

Market Cap: US$1.1b

Operates as a novel bioelectric medicine company.

Natus Medical

Market Cap: US$1.1b

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

Viridian Therapeutics

Market Cap: US$1.1b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Establishment Labs Holdings

Market Cap: US$1.1b

A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

Mineralys Therapeutics

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

10x Genomics

Market Cap: US$1.1b

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

BioLife Solutions

Market Cap: US$1.1b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Aveanna Healthcare Holdings

Market Cap: US$1.0b

A diversified home care platform company, provides pediatric and adult healthcare services in the United States.

Spire Healthcare Group

Market Cap: UK£769.3m

Owns and operates private hospitals and clinics in the United Kingdom.

Neuren Pharmaceuticals

Market Cap: AU$1.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

OPKO Health

Market Cap: US$1.0b

A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

MiMedx Group

Market Cap: US$992.6m

Develops and distributes placental tissue allografts for various sectors of healthcare.

Gyre Therapeutics

Market Cap: US$987.6m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

Integra LifeSciences Holdings

Market Cap: US$983.8m

Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

Craneware

Market Cap: UK£724.9m

Develops, licenses, and supports computer software for the healthcare industry in the United States.

Pennant Group

Market Cap: US$967.2m

Provides healthcare services in the United States.

Intellia Therapeutics

Market Cap: US$953.0m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

CareDx

Market Cap: US$949.4m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

Ardelyx

Market Cap: US$947.5m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Harrow

Market Cap: US$944.6m

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

Geron

Market Cap: US$942.6m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

NeoGenomics

Market Cap: US$936.9m

Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

CureVac

Market Cap: US$936.6m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Oculis Holding

Market Cap: US$934.5m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

Phibro Animal Health

Market Cap: US$933.1m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

Wave Life Sciences

Market Cap: US$931.0m

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Syndax Pharmaceuticals

Market Cap: US$930.2m

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Arcus Biosciences

Market Cap: US$929.7m

A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.